Comparison between Two Non-Halogenated Glucocorticoid Ointments in Psoriasis-Reference-Cited by-同舟云学术

Comparison between Two Non-Halogenated Glucocorticoid Ointments in Psoriasis

Published:1981-07 Issue:4 Volume:9 Page:239-247
ISSN:0300-0605
Container-title:Journal of International Medical Research
language:en
Short-container-title:J Int Med Res

Author:

Heijer A¹,Hesser G¹,Holm P¹,Salde L²

Affiliation:

1. Department of Dermatology, Regional Hospital, Uddevalla, Sweden

2. Medical Department, AB DRACO/TIKA (a subsidiary to AB ASTRA, Sweden), Lund, Sweden

Abstract

Observations made in a controlled double-blind investigation of two non-halogenated topical steroids, hydrocortisone-17-butyrate (HCB) and budesonide in thirty-six patients with psoriasis revealed a clear difference in therapeutic effect between the two ointments, indicating that they belong to different groups of topical steroids according to a classification accepted in the Nordic countries. Budesonide had a good therapeutic effect in all the patients studied, while, as a rule, HCB was clearly less effective.

Publisher

SAGE Publications

Subject

Biochemistry (medical),Cell Biology,Biochemistry,General Medicine

Link

http://journals.sagepub.com/doi/pdf/10.1177/030006058100900401

Reference11 articles.

1. Bleeker J, Edeland B, Eilard U, Gisslén H, Hersle K, Konstman-Meier C H, Kuokkanen K, Larsson R, Lassos L, Nordin P, Nörholm A, Svensson L, Thybo H, Unna P J, Wikström K (1980) Long-term multicentre clinical investigation of budesonide 0.025% ointment in psoriasis. In: ‘Abstracts’ the 22nd Nordic Conference on Dermatology, Helsinki. Editors: Mustakallio K and Förström L. p 178.

2. THE EFFECT ON ADRENAL FUNCTION OF TREATMENT OF ECZEMA AND PSORIASIS WITH TRIAMCINOLONE ACETONIDE

3. Cushing Syndrome From Percutaneous Absorption of Triamcinolone Cream

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New Strategies for Improving Budesonide Skin Retention;Pharmaceutics;2021-12-24

2. Validation of a HPLC-UV method for the quantification of budesonide in skin layers;Journal of Chromatography B;2021-02

3. Exosomal miRNAs as Novel Pharmacodynamic Biomarkers for Cancer Chemopreventive Agent Early Stage Treatments in Chemically Induced Mouse Model of Lung Squamous Cell Carcinoma;Cancers;2019-04-04

4. Tissue Distribution and Fate of Budesonide in the Mouse;Acta Pharmacologica et Toxicologica;2009-03-13

5. Biotransformation in vitro of the 22R and 22S epimers of budesonide by human liver, bronchus, colonic mucosa and skin;Fundamental and Clinical Pharmacology;2001-02-05